Debate An announcement by Adv. Nilesh Ojha and Ashutosh Pathak: Sahara investors By: Pooja Francis - Consultant Editor Date: September 12, 2023 FacebookTwitterPinterestWhatsApp TagsAdv. (Er.) Nilesh C. OjhaIndiaInvestorsqvive networkSahara Previous articleWatch the Special Broadcast on G20 Summit from 1 pm on Qvive OTT News NetworkNext articleThe Citizens Court of India will be held on September 16th and 17th. How will you participate in the event? LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment. Why Bill Gates is Focusing on Drills for Emergency Preparedness? Pooja Francis - Consultant Editor - May 7, 2025 Bill Gates’ Warning: His Biological and Chemical Weapons and the Four Big Dangers That Will Impact Our Future World Legal Proceedings Explained by Adv. Nilesh Ojha Debate The Link Between Guillain-Barré Syndrome and HPV Vaccine: The Truth Behind Paralysis and Deaths India The Mysterious Energy Grid Failures: Is Bill Gates Behind Them? World Covishield Vaccine Side Effects: Thrombosis and Thrombocytopenia Explained India Related articles World Why Bill Gates is Focusing on Drills for Emergency Preparedness? You know, Bill Gates has really been pushing for us to pay more attention to emergency preparedness lately.... World Bill Gates’ Warning: His Biological and Chemical Weapons and the Four Big Dangers That Will Impact Our Future Bill Gates is worried about things that aren't true: This is what is making the Microsoft founder anxious... Debate Legal Proceedings Explained by Adv. Nilesh Ojha Recently, Adv. Nilesh Ojha shared his insights on a court case, talking about what happened and emphasizing important... India The Link Between Guillain-Barré Syndrome and HPV Vaccine: The Truth Behind Paralysis and Deaths It was on January 28, 2025 that the news of the first reported death probably due to Guillain-Barré...
